{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:28:55Z","timestamp":1779316135726,"version":"3.51.4"},"posted":{"date-parts":[[2023,5,9]]},"group-title":"In Review","reference-count":31,"publisher":"Research Square Platform LLC","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,5,4]]},"abstract":"<title>Abstract<\/title>\n        <p><bold>Purpose<\/bold> This epidemiologic study evaluates the variance in incidence of Herpes Zoster (HZ) and Herpes Zoster Ophthalmicus (HZO) within a single healthcare system with an aim to analyze their relationship to the COVID-19 pandemic.<bold>Methods<\/bold> All patients attending the Duke University Health System (DUHS) from January 1, 2018, to December 31, 2021, were included.  General and COVID-related trends of HZO and HZ were analyzed based on new ICD-9 or ICD-10 diagnosis codes, compared with the total number of patients seen at DUHS during this period, and the number of reported COVID-19 cases in North Carolina obtained using the CDC data tracker.<bold>Results<\/bold> This study included 16,287 cases of HZ of whom 1,294 (7.94%) presented with HZO. The overall incidence of HZO showed an average yearly increase of 5.6%, however HZ incidence decreased by 5.3% per year. When comparing incidence rates of HZO in the 12-months before and after the COVID-19 pandemic onset in the United States (March 2020), the average incidence from March 2020 to February 2021 was 27.6\u2009\u00b1\u200911.6 compared to 18.0\u2009\u00b1\u20092.7 from March 2019 to February 2020 (p\u2009=\u20090.01). Moreover, 10\/12 (83.3%) of the months had a higher incidence rate of HZO in the post-COVID onset year compared to their corresponding month in the pre-COVID year.<bold>Conclusion<\/bold> The results show HZO incidence may be increasing, despite an overall lower HZ incidence. This could suggest a distinct mechanism for HZO appearance. The COVID pandemic, directly or indirectly, may have accelerated the already increasing HZO incidence.<\/p>","DOI":"10.21203\/rs.3.rs-2891711\/v1","type":"posted-content","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T21:34:50Z","timestamp":1683754490000},"source":"Crossref","is-referenced-by-count":4,"title":["Increasing Rates of Herpes Zoster Ophthalmicus and the COVID-19 Pandemic"],"prefix":"10.21203","author":[{"given":"Alexander J.","family":"Snyder","sequence":"first","affiliation":[{"name":"Duke University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazem M.","family":"Mousa","sequence":"additional","affiliation":[{"name":"Duke University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matias","family":"Soifer","sequence":"additional","affiliation":[{"name":"Duke University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro A","family":"Jammal","sequence":"additional","affiliation":[{"name":"Duke University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahil","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Duke Eye Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor L.","family":"Perez","sequence":"additional","affiliation":[{"name":"Duke Eye Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8761","reference":[{"issue":"5","key":"ref1","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/00005792-198209000-00003","article-title":"Population-based study of herpes zoster and its sequelae","volume":"61","author":"Ragozzino MW","year":"1982","unstructured":"Ragozzino MW, Melton LJ, 3rd, Kurland LT, Chu CP, Perry HO. (1982). Population-based study of herpes zoster and its sequelae. Medicine (Baltimore), 61(5), 310\u20136. https:\/\/doi.org\/10.1097\/00005792-198209000-00003","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"ref2","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1086\/320169","article-title":"Herpes zoster in older adults","volume":"32","author":"Schmader K","year":"2001","unstructured":"Schmader K. (2001). Herpes zoster in older adults. Clin Infect Dis, 32(10), 1481\u20136. https:\/\/doi.org\/10.1086\/320169","journal-title":"Clin Infect Dis"},{"issue":"6 Suppl","key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.08.046","article-title":"Herpes zoster: epidemiology, natural history, and common complications","volume":"57","author":"Weinberg JM","year":"2007","unstructured":"Weinberg JM. (2007). Herpes zoster: epidemiology, natural history, and common complications. J Am Acad Dermatol, 57(6 Suppl), S130-5. https:\/\/doi.org\/10.1016\/j.jaad.2007.08.046","journal-title":"J Am Acad Dermatol"},{"issue":"2 Suppl","key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.10.009","article-title":"Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity","volume":"115","author":"Liesegang TJ","year":"2008","unstructured":"Liesegang TJ. (2008). Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology, 115(2 Suppl), S3-12. https:\/\/doi.org\/10.1016\/j.ophtha.2007.10.009","journal-title":"Ophthalmology"},{"issue":"3","key":"ref5","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ophtha.2019.10.001","article-title":"Incidence Rate of Herpes Zoster Ophthalmicus: A Retrospective Cohort Study from 1994 through 2018","volume":"127","author":"Kong CL","year":"2020","unstructured":"Kong CL, Thompson RR, Porco TC, Kim E, Acharya NR. (2020). Incidence Rate of Herpes Zoster Ophthalmicus: A Retrospective Cohort Study from 1994 through 2018. Ophthalmology, 127(3), 324\u201330. https:\/\/doi.org\/10.1016\/j.ophtha.2019.10.001","journal-title":"Ophthalmology"},{"issue":"7","key":"ref6","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1097\/ICO.0b013e31823cbe6a","article-title":"Practice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus","volume":"31","author":"Sy A","year":"2012","unstructured":"Sy A, McLeod SD, Cohen EJ, et al. (2012). Practice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus. Cornea, 31(7), 786\u201390. https:\/\/doi.org\/10.1097\/ICO.0b013e31823cbe6a","journal-title":"Cornea"},{"issue":"1","key":"ref7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1086\/320884","article-title":"Characteristics of patients with herpes zoster on presentation to practitioners in France","volume":"33","author":"Chidiac C","year":"2001","unstructured":"Chidiac C, Bruxelle J, Daures JP, et al. (2001). Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis, 33(1), 62\u20139. https:\/\/doi.org\/10.1086\/320884","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"104306","DOI":"10.1016\/j.jcv.2020.104306","article-title":"Seasonality of herpes zoster and herpes zoster ophthalmicus","volume":"126","author":"Berlinberg EJ","year":"2020","unstructured":"Berlinberg EJ, Kim E, Deiner MS, Patterson C, Porco TC, Acharya NR. (2020). Seasonality of herpes zoster and herpes zoster ophthalmicus. J Clin Virol, 126, 104306. https:\/\/doi.org\/10.1016\/j.jcv.2020.104306","journal-title":"J Clin Virol"},{"issue":"5","key":"ref9","first-page":"457","article-title":"Herpes zoster in eastern Saudi Arabia: clinical presentation and management","volume":"7","author":"Alakloby OM","year":"2008","unstructured":"Alakloby OM, AlJabre SH, Randhawa MA, Alzahrani AJ, AlWunais KM, Bukhari IA. (2008). Herpes zoster in eastern Saudi Arabia: clinical presentation and management. J Drugs Dermatol, 7(5), 457\u201362.","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"ref10","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.mayocp.2013.03.014","article-title":"Herpes zoster eye complications: rates and trends","volume":"88","author":"Yawn BP","year":"2013","unstructured":"Yawn BP, Wollan PC, St Sauver JL, Butterfield LC. (2013). Herpes zoster eye complications: rates and trends. Mayo Clin Proc, 88(6), 562\u201370. https:\/\/doi.org\/10.1016\/j.mayocp.2013.03.014","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"ref11","first-page":"656","article-title":"Herpes Zoster and Postherpetic Neuralgia: Prevention and Management","volume":"96","author":"Saguil A","year":"2017","unstructured":"Saguil A, Kane S, Mercado M, Lauters R. (2017). Herpes Zoster and Postherpetic Neuralgia: Prevention and Management. Am Fam Physician, 96(10), 656\u201363.","journal-title":"Am Fam Physician"},{"issue":"7","key":"ref12","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.ophtha.2016.03.005","article-title":"Epidemiology of Herpes Zoster Ophthalmicus: Recurrence and Chronicity","volume":"123","author":"Tran KD","year":"2016","unstructured":"Tran KD, Falcone MM, Choi DS, et al. (2016). Epidemiology of Herpes Zoster Ophthalmicus: Recurrence and Chronicity. Ophthalmology, 123(7), 1469\u201375. https:\/\/doi.org\/10.1016\/j.ophtha.2016.03.005","journal-title":"Ophthalmology"},{"issue":"2","key":"ref13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/cid\/ciy954","article-title":"The Epidemiology of Herpes Zoster in the United States During the Era of Varicella and Herpes Zoster Vaccines: Changing Patterns Among Children","volume":"69","author":"Harpaz R","year":"2019","unstructured":"Harpaz R, Leung JW. (2019). The Epidemiology of Herpes Zoster in the United States During the Era of Varicella and Herpes Zoster Vaccines: Changing Patterns Among Children. Clin Infect Dis, 69(2), 345\u20137. https:\/\/doi.org\/10.1093\/cid\/ciy954","journal-title":"Clin Infect Dis"},{"issue":"6","key":"ref14","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/cid\/ciz305","article-title":"The Impact of Varicella Vaccination on the Incidence of Varicella and Herpes Zoster in the United States: Updated Evidence From Observational Databases, 1991\u20132016","volume":"70","author":"Wolfson LJ","year":"2020","unstructured":"Wolfson LJ, Daniels VJ, Altland A, Black W, Huang W, Ou W. (2020). The Impact of Varicella Vaccination on the Incidence of Varicella and Herpes Zoster in the United States: Updated Evidence From Observational Databases, 1991\u20132016. Clin Infect Dis, 70(6), 995\u20131002. https:\/\/doi.org\/10.1093\/cid\/ciz305","journal-title":"Clin Infect Dis"},{"issue":"6","key":"ref15","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1080\/21645515.2020.1847582","article-title":"A systematic literature review of herpes zoster incidence worldwide","volume":"17","author":"Oorschot D","year":"2021","unstructured":"van Oorschot D, Vroling H, Bunge E, Diaz-Decaro J, Curran D, Yawn B. (2021). A systematic literature review of herpes zoster incidence worldwide. Hum Vaccin Immunother, 17(6), 1714\u201332. https:\/\/doi.org\/10.1080\/21645515.2020.1847582","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"ref16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/cid\/ciy953","article-title":"The Epidemiology of Herpes Zoster in the United States During the Era of Varicella and Herpes Zoster Vaccines: Changing Patterns Among Older Adults","volume":"69","author":"Harpaz R","year":"2019","unstructured":"Harpaz R, Leung JW. (2019). The Epidemiology of Herpes Zoster in the United States During the Era of Varicella and Herpes Zoster Vaccines: Changing Patterns Among Older Adults. Clin Infect Dis, 69(2), 341\u20134. https:\/\/doi.org\/10.1093\/cid\/ciy953","journal-title":"Clin Infect Dis"},{"issue":"4","key":"ref17","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.vaccine.2008.11.012","article-title":"Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older","volume":"27","author":"Stein AN","year":"2009","unstructured":"Stein AN, Britt H, Harrison C, Conway EL, Cunningham A, Macintyre CR. (2009). Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older. Vaccine, 27(4), 520\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2008.11.012","journal-title":"Vaccine"},{"issue":"3","key":"ref18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu B","year":"2021","unstructured":"Hu B, Guo H, Zhou P, Shi ZL. (2021). Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol, 19(3), 141\u201354. https:\/\/doi.org\/10.1038\/s41579-020-00459-7","journal-title":"Nat Rev Microbiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.ijid.2021.02.033","article-title":"Increased number of Herpes Zoster cases in Brazil related to the COVID-19 pandemic","volume":"104","author":"Maia CMF","year":"2021","unstructured":"Maia CMF, Marques NP, de Lucena EHG, de Rezende LF, Martelli DRB, Martelli-Junior H. (2021). Increased number of Herpes Zoster cases in Brazil related to the COVID-19 pandemic. Int J Infect Dis, 104, 732\u20133. https:\/\/doi.org\/10.1016\/j.ijid.2021.02.033","journal-title":"Int J Infect Dis"},{"issue":"5","key":"ref20","doi-asserted-by":"publisher","first-page":"ofac118","DOI":"10.1093\/ofid\/ofac118","article-title":"Increased Risk of Herpes Zoster in Adults >\/=50 Years Old Diagnosed With COVID-19 in the United States","volume":"9","author":"Bhavsar A","year":"2022","unstructured":"Bhavsar A, Lonnet G, Wang C, et al. (2022). Increased Risk of Herpes Zoster in Adults >\/=50 Years Old Diagnosed With COVID-19 in the United States. Open Forum Infect Dis, 9(5), ofac118. https:\/\/doi.org\/10.1093\/ofid\/ofac118","journal-title":"Open Forum Infect Dis"},{"issue":"25","key":"ref21","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1016\/j.vaccine.2003.10.042","article-title":"Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology","volume":"23","author":"Goldman GS","year":"2005","unstructured":"Goldman GS. (2005). Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology. Vaccine, 23(25), 3349\u201355. https:\/\/doi.org\/10.1016\/j.vaccine.2003.10.042","journal-title":"Vaccine"},{"issue":"5","key":"ref22","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/ICO.0000000000000362","article-title":"Factors associated with age of onset of herpes zoster ophthalmicus","volume":"34","author":"Chan AY","year":"2015","unstructured":"Chan AY, Conrady CD, Ding K, Dvorak JD, Stone DU. (2015). Factors associated with age of onset of herpes zoster ophthalmicus. Cornea, 34(5), 535\u201340. https:\/\/doi.org\/10.1097\/ICO.0000000000000362","journal-title":"Cornea"},{"issue":"6","key":"ref23","doi-asserted-by":"publisher","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai K","year":"2014","unstructured":"Kawai K, Gebremeskel BG, Acosta CJ. (2014). Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open, 4(6), e004833. https:\/\/doi.org\/10.1136\/bmjopen-2014-004833","journal-title":"BMJ Open"},{"issue":"2","key":"ref24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1001\/jama.2010.1983","article-title":"Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease","volume":"305","author":"Tseng HF","year":"2011","unstructured":"Tseng HF, Smith N, Harpaz R, Bialek SR, Sy LS, Jacobsen SJ. (2011). Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA, 305(2), 160\u20136. https:\/\/doi.org\/10.1001\/jama.2010.1983","journal-title":"JAMA"},{"issue":"12","key":"ref25","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.ophtha.2021.04.017","article-title":"Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States","volume":"128","author":"Lu A","year":"2021","unstructured":"Lu A, Sun Y, Porco TC, Arnold BF, Acharya NR. (2021). Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States. Ophthalmology, 128(12), 1699\u2013707. https:\/\/doi.org\/10.1016\/j.ophtha.2021.04.017","journal-title":"Ophthalmology"},{"issue":"1","key":"ref26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/s1473-3099(03)00857-0","article-title":"What does epidemiology tell us about risk factors for herpes zoster?","volume":"4","author":"Thomas SL","year":"2004","unstructured":"Thomas SL, Hall AJ. (2004). What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis, 4(1), 26\u201333. https:\/\/doi.org\/10.1016\/s1473-3099(03)00857-0","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"ref27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/cid\/ciw296","article-title":"Increasing Incidence of Herpes Zoster Over a 60-year Period From a Population-based Study","volume":"63","author":"Kawai K","year":"2016","unstructured":"Kawai K, Yawn BP, Wollan P, Harpaz R. (2016). Increasing Incidence of Herpes Zoster Over a 60-year Period From a Population-based Study. Clin Infect Dis, 63(2), 221\u20136. https:\/\/doi.org\/10.1093\/cid\/ciw296","journal-title":"Clin Infect Dis"},{"issue":"221","key":"ref28","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/infdis\/jiaa150","article-title":"Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia","volume":"11","author":"Wang FNJ","year":"2020","unstructured":"Wang F NJ, Wang H, Zhao Q, Xiong Y, Deng L, Song S, Ma Z, Mo P, Zhang Y. (2020). Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia. J Infect Dis, 11(221), 1762\u20139. https:\/\/doi.org\/10.1093\/infdis\/jiaa150","journal-title":"J Infect Dis"},{"issue":"1","key":"ref29","doi-asserted-by":"publisher","first-page":"e51-e60","DOI":"10.1016\/j.jinf.2020.04.012","article-title":"Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China","volume":"81","author":"Xu B","year":"2020","unstructured":"Xu B, Fan CY, Wang AL, et al. (2020). Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China. J Infect, 81(1), e51-e60. https:\/\/doi.org\/10.1016\/j.jinf.2020.04.012","journal-title":"J Infect"},{"issue":"1","key":"ref30","doi-asserted-by":"publisher","first-page":"15039","DOI":"10.1038\/s41598-017-15390-w","article-title":"Decreased absolute numbers of CD3(+) T cells and CD8(+) T cells during aging in herpes zoster patients","volume":"7","author":"Wei L","year":"2017","unstructured":"Wei L, Zhao J, Wu W, et al. (2017). Decreased absolute numbers of CD3(+) T cells and CD8(+) T cells during aging in herpes zoster patients. Sci Rep, 7(1), 15039. https:\/\/doi.org\/10.1038\/s41598-017-15390-w","journal-title":"Sci Rep"},{"issue":"11","key":"ref31","doi-asserted-by":"publisher","first-page":"922","DOI":"10.7326\/0003-4819-130-11-199906010-00017","article-title":"Recent advances in varicella-zoster virus infection","volume":"130","author":"Cohen JI","year":"1999","unstructured":"Cohen JI, Brunell PA, Straus SE, Krause PR. (1999). Recent advances in varicella-zoster virus infection. Ann Intern Med, 130(11), 922\u201332. https:\/\/doi.org\/10.7326\/0003-4819-130-11-199906010-00017","journal-title":"Ann Intern Med"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2891711\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2891711\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T04:59:31Z","timestamp":1684645171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2891711\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":31,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-2891711\/v1","relation":{},"subject":[],"published":{"date-parts":[[2023,5,9]]},"subtype":"preprint"}}